Fundies.
Español

Operaciones de insiders

EDGAR

Heartflow, Inc.

Operaciones informadas por directores, ejecutivos y titulares de más del 10 % en los Formularios 3, 4 y 5 de la SEC, leídas del XML de cada presentación. Los códigos y su redacción son los de la SEC.

El Formulario 4 debe presentarse dentro de los dos días hábiles posteriores a la operación, por lo que las más recientes pueden no estar presentadas aún.

Ventana: operaciones con fecha desde el 15 nov 2025.

Compras en el mercado abierto (código P)
1 operaciones, 40.000 acciones
Suma de acciones × precio por acción: 1.053.680
Ventas en el mercado abierto (código S)
40 operaciones, 4.774.576 acciones
Suma de acciones × precio por acción: 143.680.202,6078

Los totales suman las operaciones presentadas que se listan; cuentan lo informado y no miden una dirección.

Mostrando 1–50 de 147

Operaciones de insiders, las más recientes primero, según los Formularios 3, 4 y 5 de la SEC
FechaTitular informanteCódigoAdquirido o enajenadoAccionesPrecio por acción, según lo presentadoValor (derivado)Acciones poseídas despuésDirecta o indirectaCasilla de la Regla 10b5-1NotasFuente
10 nov 2026 Presentado el 10 nov 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Adquirido (A)15.6202,22
34.676,4

Derivado: acciones × precio por acción. Valor exacto 34676.40.

290.883Directa (D) Sí
F2
  • F2 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
Abrir presentación 0001464521-26-000168 Leído del XML de la presentación Disputar esta fila
10 nov 2026 Presentado el 10 nov 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)38.90055,74
2.168.286

Derivado: acciones × precio por acción. Valor exacto 2168286.00.

251.983Directa (D) Sí
F3
  • F3 Includes the sale of 23,280 shares of common stock held and the option exercise and sale of 15,620 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
Abrir presentación 0001464521-26-000168 Leído del XML de la presentación Disputar esta fila
10 nov 2026 Presentado el 10 nov 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Stock Option — subyacente Common Stock (15.620) — precio de ejercicio 2.22		Enajenado (D)15.6200—1.969.017Directa (D) Sí
F2, F4
  • F2 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
  • F4 The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
Abrir presentación 0001464521-26-000168 Leído del XML de la presentación Disputar esta fila
9 nov 2026 Presentado el 10 nov 2026Verghese Vikram Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock.		Enajenado (D)358753,15
190.649,05

Derivado: acciones × precio por acción. Valor exacto 190649.05.

149.587Directa (D) Sí
F2
  • F2 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
Abrir presentación 0001464521-26-000166 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Jones Marie L. Officer: Chief Accounting Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock.		Enajenado (D)56852,40
29.763,2

Derivado: acciones × precio por acción. Valor exacto 29763.20.

32.403Directa (D) No
F2
  • F2 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000161 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Verghese Vikram Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock.		Enajenado (D)200952,40
105.271,6

Derivado: acciones × precio por acción. Valor exacto 105271.60.

153.174Directa (D) Sí
F1
  • F1 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000166 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Rogers Campbell Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock		Enajenado (D)227052,40
118.948

Derivado: acciones × precio por acción. Valor exacto 118948.00.

71.183Directa (D) No
F1
  • F1 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000163 Leído del XML de la presentación Disputar esta fila
6 nov 2026 Presentado el 10 nov 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock		Enajenado (D)775152,40
406.152,4

Derivado: acciones × precio por acción. Valor exacto 406152.40.

275.263Directa (D) Sí
F1
  • F1 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000168 Leído del XML de la presentación Disputar esta fila
22 oct 2026 Presentado el 26 oct 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Adquirido (A)12.3298,33
102.700,57

Derivado: acciones × precio por acción. Valor exacto 102700.57.

92.285Directa (D) Sí
F1
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
Abrir presentación 0001464521-26-000156 Leído del XML de la presentación Disputar esta fila
22 oct 2026 Presentado el 26 oct 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Adquirido (A)51012,22
11.324,22

Derivado: acciones × precio por acción. Valor exacto 11324.22.

97.386Directa (D) Sí
F1
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
Abrir presentación 0001464521-26-000156 Leído del XML de la presentación Disputar esta fila
22 oct 2026 Presentado el 26 oct 2026Rogers Campbell Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)23.93355,01
1.316.554,33

Derivado: acciones × precio por acción. Valor exacto 1316554.33.

73.453Directa (D) Sí
F2
  • F2 Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 17,430 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
Abrir presentación 0001464521-26-000156 Leído del XML de la presentación Disputar esta fila
22 oct 2026 Presentado el 26 oct 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Stock Option — subyacente Common Stock (12.329) — precio de ejercicio 8.33		Enajenado (D)12.3290—19.127Directa (D) Sí
F1, F3
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
  • F3 These stock options are fully exercisable.
Abrir presentación 0001464521-26-000156 Leído del XML de la presentación Disputar esta fila
22 oct 2026 Presentado el 26 oct 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Stock Option — subyacente Common Stock (5101) — precio de ejercicio 2.22		Enajenado (D)51010—65.682Directa (D) Sí
F1, F4
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
  • F4 The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
Abrir presentación 0001464521-26-000156 Leído del XML de la presentación Disputar esta fila
12 oct 2026 Presentado el 14 oct 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)38.90049,568
1.928.195,2

Derivado: acciones × precio por acción. Valor exacto 1928195.200.

283.014Directa (D) Sí
F1, F2
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
  • F2 This transaction was executed in multiple trades at price ranging from $49.52 to $50.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Abrir presentación 0001464521-26-000154 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 21 sept 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Adquirido (A)12.3298,33
102.700,57

Derivado: acciones × precio por acción. Valor exacto 102700.57.

98.788Directa (D) Sí
F1
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
Abrir presentación 0001464521-26-000152 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 21 sept 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Adquirido (A)8502,22
1887

Derivado: acciones × precio por acción. Valor exacto 1887.00.

99.638Directa (D) Sí
F1
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
Abrir presentación 0001464521-26-000152 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 21 sept 2026Rogers Campbell Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)19.68250,15
987.052,3

Derivado: acciones × precio por acción. Valor exacto 987052.30.

79.956Directa (D) Sí
F2
  • F2 Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 13,179 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
Abrir presentación 0001464521-26-000152 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 21 sept 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Stock Option — subyacente Common Stock (12.329) — precio de ejercicio 8.33		Enajenado (D)12.3290—31.456Directa (D) Sí
F1, F3
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
  • F3 These stock options are fully exercisable.
Abrir presentación 0001464521-26-000152 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 21 sept 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Stock Option — subyacente Common Stock (850) — precio de ejercicio 2.22		Enajenado (D)8500—70.783Directa (D) Sí
F1, F4
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
  • F4 The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
Abrir presentación 0001464521-26-000152 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 18 sept 2026Verghese Vikram Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock.		Enajenado (D)16.76650,7531
850.926,4746

Derivado: acciones × precio por acción. Valor exacto 850926.4746.

155.183Directa (D) Sí
F1, F3
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
  • F3 This transaction was executed in multiple trades at price ranging from $50.00 to $52.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Abrir presentación 0001464521-26-000149 Leído del XML de la presentación Disputar esta fila
17 sept 2026 Presentado el 18 sept 2026Verghese Vikram Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock.		Enajenado (D)757950,1142
379.815,5218

Derivado: acciones × precio por acción. Valor exacto 379815.5218.

171.949Directa (D) Sí
F1, F2
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
  • F2 This transaction was executed in multiple trades at price ranging from $50.00 to $50.29. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Abrir presentación 0001464521-26-000149 Leído del XML de la presentación Disputar esta fila
15 sept 2026 Presentado el 15 sept 2026Verghese Vikram Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock.		Enajenado (D)66850,012
33.408,016

Derivado: acciones × precio por acción. Valor exacto 33408.016.

179.528Directa (D) Sí
F1, F4
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
  • F4 This transaction was executed in multiple trades at price ranging from $50.00 to $50.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Abrir presentación 0001464521-26-000147 Leído del XML de la presentación Disputar esta fila
14 sept 2026 Presentado el 15 sept 2026Verghese Vikram Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock.		Enajenado (D)459350,2381
230.743,5933

Derivado: acciones × precio por acción. Valor exacto 230743.5933.

180.196Directa (D) Sí
F1, F3
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
  • F3 This transaction was executed in multiple trades at price ranging from $50.00 to $50.62. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Abrir presentación 0001464521-26-000147 Leído del XML de la presentación Disputar esta fila
11 sept 2026 Presentado el 15 sept 2026Verghese Vikram Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock.		Enajenado (D)29.71450,0592
1.487.459,0688

Derivado: acciones × precio por acción. Valor exacto 1487459.0688.

184.789Directa (D) Sí
F1, F2
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
  • F2 This transaction was executed in multiple trades at price ranging from $50.06 to $50.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Abrir presentación 0001464521-26-000147 Leído del XML de la presentación Disputar esta fila
11 sept 2026 Presentado el 14 sept 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)389050,00
194.500

Derivado: acciones × precio por acción. Valor exacto 194500.00.

321.914Directa (D) Sí
F1
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
Abrir presentación 0001464521-26-000145 Leído del XML de la presentación Disputar esta fila
10 sept 2026 Presentado el 14 sept 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)35.01046,4183
1.625.104,683

Derivado: acciones × precio por acción. Valor exacto 1625104.6830.

325.804Directa (D) Sí
F1, F2
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
  • F2 This transaction was executed in multiple trades at price ranging from $45.43 to $47.78. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Abrir presentación 0001464521-26-000145 Leído del XML de la presentación Disputar esta fila
8 sept 2026 Presentado el 10 nov 2026Jones Marie L. Officer: Chief Accounting Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock.		Adquirido (A)79519,70
15.661,5

Derivado: acciones × precio por acción. Valor exacto 15661.50.

32.971Directa (D) No
F1
  • F1 These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
Abrir presentación 0001464521-26-000161 Leído del XML de la presentación Disputar esta fila
8 sept 2026 Presentado el 10 sept 2026Verghese Vikram Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock.		Enajenado (D)664050,0319
332.211,816

Derivado: acciones × precio por acción. Valor exacto 332211.8160.

214.503Directa (D) Sí
F1, F2
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
  • F2 This transaction was executed in multiple trades at price ranging from $50.00 to $50.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Abrir presentación 0001464521-26-000143 Leído del XML de la presentación Disputar esta fila
3 sept 2026 Presentado el 4 sept 2026Verghese Vikram Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock.		Enajenado (D)27.54049,6903
1.368.470,862

Derivado: acciones × precio por acción. Valor exacto 1368470.8620.

221.143Directa (D) Sí
F1, F2
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
  • F2 This transaction was executed in multiple trades at price ranging from $48.22 to $50.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Abrir presentación 0001464521-26-000141 Leído del XML de la presentación Disputar esta fila
2 sept 2026 Presentado el 4 sept 2026Verghese Vikram Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock.		Enajenado (D)587650,60
297.325,6

Derivado: acciones × precio por acción. Valor exacto 297325.60.

248.683Directa (D) Sí
F1
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2026.
Abrir presentación 0001464521-26-000141 Leído del XML de la presentación Disputar esta fila
21 ago 2026 Presentado el 25 ago 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)27.23050,00
1.361.500

Derivado: acciones × precio por acción. Valor exacto 1361500.00.

360.814Directa (D) Sí
F1
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
Abrir presentación 0001464521-26-000139 Leído del XML de la presentación Disputar esta fila
18 ago 2026 Presentado el 20 ago 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)32.67645,00
1.470.420

Derivado: acciones × precio por acción. Valor exacto 1470420.00.

388.044Directa (D) Sí
F1
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
Abrir presentación 0001464521-26-000137 Leído del XML de la presentación Disputar esta fila
17 ago 2026 Presentado el 19 ago 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Adquirido (A)921919,00
175.161

Derivado: acciones × precio por acción. Valor exacto 175161.00.

95.678Directa (D) Sí
F1
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.
Abrir presentación 0001464521-26-000135 Leído del XML de la presentación Disputar esta fila
17 ago 2026 Presentado el 19 ago 2026Rogers Campbell Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)921941,23
380.099,37

Derivado: acciones × precio por acción. Valor exacto 380099.37.

86.459Directa (D) Sí
F1
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.
Abrir presentación 0001464521-26-000135 Leído del XML de la presentación Disputar esta fila
17 ago 2026 Presentado el 19 ago 2026Rogers Campbell Officer: Chief Medical Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Stock Options — subyacente Common Stock (9219) — precio de ejercicio 19.00		Enajenado (D)92190—82.972Directa (D) Sí
F1, F2
  • F1 The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.
  • F2 The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.
Abrir presentación 0001464521-26-000135 Leído del XML de la presentación Disputar esta fila
14 ago 2026 Presentado el 18 ago 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)15.56039,06
607.773,6

Derivado: acciones × precio por acción. Valor exacto 607773.60.

420.720Directa (D) Sí
F1
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
Abrir presentación 0001464521-26-000133 Leído del XML de la presentación Disputar esta fila
10 ago 2026 Presentado el 12 ago 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Enajenado (D)22.56228,31
638.730,22

Derivado: acciones × precio por acción. Valor exacto 638730.22.

436.280Directa (D) Sí
F1
  • F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
Abrir presentación 0001464521-26-000127 Leído del XML de la presentación Disputar esta fila
7 ago 2026 Presentado el 10 ago 2026Verghese Vikram Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock.		Enajenado (D)47328,82
13.631,86

Derivado: acciones × precio por acción. Valor exacto 13631.86.

254.559Directa (D) No
F2
  • F2 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000121 Leído del XML de la presentación Disputar esta fila
7 ago 2026 Presentado el 10 ago 2026Jones Marie L. Officer: Chief Accounting Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock.		Enajenado (D)8228,82
2363,24

Derivado: acciones × precio por acción. Valor exacto 2363.24.

32.176Directa (D) No
F2
  • F2 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000123 Leído del XML de la presentación Disputar esta fila
7 ago 2026 Presentado el 10 ago 2026Rogers Campbell Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock		Enajenado (D)63728,82
18.358,34

Derivado: acciones × precio por acción. Valor exacto 18358.34.

86.459Directa (D) No
F1
  • F1 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000119 Leído del XML de la presentación Disputar esta fila
7 ago 2026 Presentado el 10 ago 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock		Enajenado (D)190428,82
54.873,28

Derivado: acciones × precio por acción. Valor exacto 54873.28.

458.842Directa (D) No
F1
  • F1 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000117 Leído del XML de la presentación Disputar esta fila
6 ago 2026 Presentado el 10 ago 2026Verghese Vikram Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock.		Enajenado (D)153727,19
41.791,03

Derivado: acciones × precio por acción. Valor exacto 41791.03.

255.032Directa (D) No
F2
  • F2 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000121 Leído del XML de la presentación Disputar esta fila
6 ago 2026 Presentado el 10 ago 2026Jones Marie L. Officer: Chief Accounting Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock.		Enajenado (D)48627,19
13.214,34

Derivado: acciones × precio por acción. Valor exacto 13214.34.

32.258Directa (D) No
F2
  • F2 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000123 Leído del XML de la presentación Disputar esta fila
6 ago 2026 Presentado el 10 ago 2026Rogers Campbell Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock		Enajenado (D)163527,19
44.455,65

Derivado: acciones × precio por acción. Valor exacto 44455.65.

87.096Directa (D) No
F1
  • F1 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000119 Leído del XML de la presentación Disputar esta fila
6 ago 2026 Presentado el 10 ago 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock		Enajenado (D)584727,19
158.979,93

Derivado: acciones × precio por acción. Valor exacto 158979.93.

460.746Directa (D) No
F1
  • F1 Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
Abrir presentación 0001464521-26-000117 Leído del XML de la presentación Disputar esta fila
30 jul 2026 Presentado el 31 jul 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Adquirido (A)27898,33
23.232,37

Derivado: acciones × precio por acción. Valor exacto 23232.37.

438.162Directa (D) No— Abrir presentación 0001464521-26-000115 Leído del XML de la presentación Disputar esta fila
30 jul 2026 Presentado el 31 jul 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Adquirido (A)18.6942,22
41.500,68

Derivado: acciones × precio por acción. Valor exacto 41500.68.

456.856Directa (D) No— Abrir presentación 0001464521-26-000115 Leído del XML de la presentación Disputar esta fila
30 jul 2026 Presentado el 31 jul 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Adquirido (A)97379,58
93.280,46

Derivado: acciones × precio por acción. Valor exacto 93280.46.

466.593Directa (D) No— Abrir presentación 0001464521-26-000115 Leído del XML de la presentación Disputar esta fila
30 jul 2026 Presentado el 31 jul 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Stock Option — subyacente Common Stock (18.694) — precio de ejercicio 2.22		Enajenado (D)18.6940—1.984.637Directa (D) No
F1
  • F1 The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
Abrir presentación 0001464521-26-000115 Leído del XML de la presentación Disputar esta fila
30 jul 2026 Presentado el 31 jul 2026Farquhar John C.M. Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor derivado: Stock Option — subyacente Common Stock (2789) — precio de ejercicio 8.33		Enajenado (D)27890—65.703Directa (D) No
F2
  • F2 These stock options are fully exercisable.
Abrir presentación 0001464521-26-000115 Leído del XML de la presentación Disputar esta fila

Titulares institucionales (Formulario 13F)

Trimestre terminado el 2026-09-30: 7211 presentaciones leídas, la última del 13 nov 2026. Trimestre anterior terminado el 2026-06-30: 9150 presentaciones leídas.

Mostrando 1–50 de 176

Titulares institucionales, la posición mayor primero, según lo presentado
GestorAcciones o principalValor según lo presentadoDiferencia con el trimestre anteriorFuente
BlackRock, Inc. Informado en parte bajo otro gestor6.040.943 SH300.536.917 dólaresMayor en 843.196 Trimestre anterior: 5.197.747Abrir presentación 0002012383-26-003985 Presentado el 13 nov 2026 Disputar esta fila
FMR LLC Informado en parte bajo otro gestor5.491.275 SH273.190.930 dólaresMayor en 670.331 Trimestre anterior: 4.820.944Abrir presentación 0000315066-26-002964 Presentado el 10 nov 2026 Disputar esta fila
VANGUARD PORTFOLIO MANAGEMENT LLC 3.719.472 SH185.043.732 dólaresMayor en 135.044 Trimestre anterior: 3.584.428Abrir presentación 0002100121-26-001150 Presentado el 13 nov 2026 Disputar esta fila
VANGUARD CAPITAL MANAGEMENT LLC 3.315.690 SH164.955.578 dólaresMayor en 562.484 Trimestre anterior: 2.753.206Abrir presentación 0002100119-26-001711 Presentado el 13 nov 2026 Disputar esta fila
Invesco Ltd. Informado en parte bajo otro gestor2.693.251 SH133.989.238 dólaresMayor en 394.533 Trimestre anterior: 2.298.718Abrir presentación 0000914208-26-000462 Presentado el 12 nov 2026 Disputar esta fila
GEODE CAPITAL MANAGEMENT, LLC Informado en parte bajo otro gestor1.817.385 SH90.431.957 dólaresMayor en 456.994 Trimestre anterior: 1.360.391Abrir presentación 0001214717-26-000012 Presentado el 6 nov 2026 Disputar esta fila
STATE STREET CORP Informado en parte bajo otro gestor1.733.396 SH86.236.451 dólaresMayor en 267.501 Trimestre anterior: 1.465.895Abrir presentación 0000093751-26-000747 Presentado el 12 nov 2026 Disputar esta fila
MORGAN STANLEY Informado en parte bajo otro gestor1.429.097 SH71.097.711 dólaresMayor en 374.208 Trimestre anterior: 1.054.889Abrir presentación 0000895421-26-000309 Presentado el 13 nov 2026 Disputar esta fila
Nuveen, LLC Informado en parte bajo otro gestor1.405.248 SH69.911.088 dólaresMayor en 52.080 Trimestre anterior: 1.353.168Abrir presentación 0000930413-26-003284 Presentado el 10 nov 2026 Disputar esta fila
FRANKLIN TEMPLETON INC Informado en parte bajo otro gestor1.102.885 SH62.390.204 dólaresMayor en 285.184 Trimestre anterior: 817.701Abrir presentación 0000038777-26-000291 Presentado el 12 nov 2026 Disputar esta fila
Walleye Capital LLC 1.044.902 SH51.983.875 dólaresMayor en 746.334 Trimestre anterior: 298.568Abrir presentación 0001758720-26-000007 Presentado el 13 nov 2026 Disputar esta fila
RENAISSANCE TECHNOLOGIES LLC Informado en parte bajo otro gestor993.900 SH49.446.525 dólaresMayor en 611.200 Trimestre anterior: 382.700Abrir presentación 0001037389-26-000062 Presentado el 12 nov 2026 Disputar esta fila
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Informado en parte bajo otro gestor932.884 SH46.410.979 dólaresMayor en 1724 Trimestre anterior: 931.160Abrir presentación 0001520354-26-000046 Presentado el 13 nov 2026 Disputar esta fila
UBS Group AG Informado en parte bajo otro gestor847.278 SH42.152.081 dólaresMenor en 128.232 Trimestre anterior: 975.510Abrir presentación 0001610520-26-000121 Presentado el 10 nov 2026 Disputar esta fila
EVENTIDE ASSET MANAGEMENT, LLC 754.232 SH37.523.085 dólaresMayor en 117.290 Trimestre anterior: 636.942Abrir presentación 0001580642-26-007711 Presentado el 13 nov 2026 Disputar esta fila
NZS Capital, LLC 677.362 SH33.698.760 dólaresMayor en 21.348 Trimestre anterior: 656.014Abrir presentación 0001816616-26-000006 Presentado el 13 nov 2026 Disputar esta fila
NEXT CENTURY GROWTH INVESTORS LLC 590.745 SH29.389.564 dólaresMenor en 80.659 Trimestre anterior: 671.404Abrir presentación 0001134007-26-000007 Presentado el 13 nov 2026 Disputar esta fila
BNP PARIBAS FINANCIAL MARKETS Informado en parte bajo otro gestor574.671 SH28.589.882 dólaresMayor en 63.148 Trimestre anterior: 511.523Abrir presentación 0001166588-26-000012 Presentado el 12 nov 2026 Disputar esta fila
VOYA INVESTMENT MANAGEMENT LLC Informado en parte bajo otro gestor545.795 SH27.153.302 dólaresMenor en 187.388 Trimestre anterior: 733.183Abrir presentación 0001068837-26-000006 Presentado el 10 nov 2026 Disputar esta fila
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 499.984 SH24.874.204 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0001535845-26-000011 Presentado el 13 nov 2026 Disputar esta fila
VANGUARD FIDUCIARY TRUST CO 495.600 SH24.656.100 dólaresMayor en 259.791 Trimestre anterior: 235.809Abrir presentación 0000933478-26-000017 Presentado el 13 nov 2026 Disputar esta fila
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Informado en parte bajo otro gestor476.509 SH23.706.323 dólaresMenor en 22.303 Trimestre anterior: 498.812Abrir presentación 0000912938-26-001073 Presentado el 12 nov 2026 Disputar esta fila
LORD, ABBETT CO. LLC 437.768 SH21.779 dólaresMayor en 237.232 Trimestre anterior: 200.536Abrir presentación 0000930413-26-003314 Presentado el 13 nov 2026 Disputar esta fila
FEDERATED HERMES, INC. Informado en parte bajo otro gestor394.190 SH19.610.952 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0001623632-26-001675 Presentado el 12 nov 2026 Disputar esta fila
Champlain Investment Partners, LLC 380.137 SH18.911.816 dólaresMenor en 353.470 Trimestre anterior: 733.607Abrir presentación 0001315478-26-000027 Presentado el 12 nov 2026 Disputar esta fila
JPMORGAN CHASE CO Informado en parte bajo otro gestor374.656 SH18.876.148 dólaresMenor en 66.581 Trimestre anterior: 441.237Abrir presentación 0000019617-26-000404 Presentado el 12 nov 2026 Disputar esta fila
HRT FINANCIAL LP 346.427 SH17.234 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0001475597-26-000249 Presentado el 13 nov 2026 Disputar esta fila
MG PLC Informado en parte bajo otro gestor319.558 SH15.977.900 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0001193125-26-446555 Presentado el 4 nov 2026 Disputar esta fila
Bank of New York Mellon Corp Informado en parte bajo otro gestor302.658 SH15.057.273 dólaresMenor en 348.191 Trimestre anterior: 650.849Abrir presentación 0001390777-26-000121 Presentado el 5 nov 2026 Disputar esta fila
Squarepoint Ops LLC Informado en parte bajo otro gestor246.207 SH12.248.798 dólaresMayor en 159.155 Trimestre anterior: 87.052Abrir presentación 0001642575-26-000012 Presentado el 9 nov 2026 Disputar esta fila
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Informado en parte bajo otro gestor244.110 SH12.144.473 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0001164508-26-000060 Presentado el 13 nov 2026 Disputar esta fila
Jump Financial, LLC Informado en parte bajo otro gestor211.646 SH10.529.389 dólaresMayor en 161.624 Trimestre anterior: 50.022Abrir presentación 0000905148-26-004786 Presentado el 13 nov 2026 Disputar esta fila
DEUTSCHE BANK AG\ Informado en parte bajo otro gestor209.739 SH10.434.516 dólaresMayor en 130.659 Trimestre anterior: 79.080Abrir presentación 0000948046-26-000083 Presentado el 6 nov 2026 Disputar esta fila
Temasek Holdings (Private) Ltd Informado en parte bajo otro gestor201.610 SH10.030.098 dólaresMayor en 43.966 Trimestre anterior: 157.644Abrir presentación 0001021944-26-000015 Presentado el 28 oct 2026 Disputar esta fila
SEI INVESTMENTS CO Informado en parte bajo otro gestor165.440 SH8.230.652 dólaresMayor en 2431 Trimestre anterior: 163.009Abrir presentación 0000350894-26-000059 Presentado el 10 nov 2026 Disputar esta fila
Lisanti Capital Growth, LLC 155.295 SH7.725.926 dólaresMenor en 34.380 Trimestre anterior: 189.675Abrir presentación 0001424467-26-000004 Presentado el 5 nov 2026 Disputar esta fila
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 151.821 SH7.231.243 dólaresMenor en 15.385 Trimestre anterior: 167.206Abrir presentación 0001214659-26-012804 Presentado el 13 oct 2026 Disputar esta fila
BARCLAYS PLC Informado en parte bajo otro gestor147.764 SH7.351.259 dólaresMayor en 122.953 Trimestre anterior: 24.811Abrir presentación 0000312069-26-000241 Presentado el 6 nov 2026 Disputar esta fila
Swiss National Bank 135.200 SH6.726.200 dólaresMayor en 57.800 Trimestre anterior: 77.400Abrir presentación 0001582202-26-000008 Presentado el 12 nov 2026 Disputar esta fila
FORA Capital, LLC 119.303 SH5.935.324 dólaresMayor en 100.457 Trimestre anterior: 18.846Abrir presentación 0001742435-26-000002 Presentado el 13 nov 2026 Disputar esta fila
Quantinno Capital Management LP 118.176 SH5.879.265 dólaresMayor en 42.589 Trimestre anterior: 75.587Abrir presentación 0001759654-26-000011 Presentado el 13 nov 2026 Disputar esta fila
Universal- Beteiligungs- und Servicegesellschaft mbH Informado en parte bajo otro gestor115.041 SH5.723.292 dólaresMayor en 59.874 Trimestre anterior: 55.167Abrir presentación 0002057170-26-000022 Presentado el 10 nov 2026 Disputar esta fila
Qube Research Technologies Ltd 101.237 SH5.036.541 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0001729829-26-000018 Presentado el 13 nov 2026 Disputar esta fila
BROWN CAPITAL MANAGEMENT LLC 101.190 SH5.034.203 dólaresMayor en 19.099 Trimestre anterior: 82.091Abrir presentación 0001398344-26-018883 Presentado el 27 oct 2026 Disputar esta fila
RHUMBLINE ADVISERS 98.571 SH4.903.898 dólaresMayor en 4751 Trimestre anterior: 93.820Abrir presentación 0001115418-26-000015 Presentado el 10 nov 2026 Disputar esta fila
BCWM, LLC 89.960 SH4.475.510 dólaresMayor en 58.082 Trimestre anterior: 31.878Abrir presentación 0001542165-26-000004 Presentado el 12 nov 2026 Disputar esta fila
RAYMOND JAMES FINANCIAL INC Informado en parte bajo otro gestor80.971 SH4.028.308 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0000720005-26-000081 Presentado el 12 nov 2026 Disputar esta fila
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 76.882 SH3.824.880 dólaresMayor en 32.901 Trimestre anterior: 43.981Abrir presentación 0001081019-26-000023 Presentado el 13 nov 2026 Disputar esta fila
Ensign Peak Advisors, Inc 68.058 SH3.385.886 dólaresMayor en 3456 Trimestre anterior: 64.602Abrir presentación 0001454984-26-000011 Presentado el 12 nov 2026 Disputar esta fila
XXEC, Inc. 60.040 SH2.986.990 dólaresMenor en 539.154 Trimestre anterior: 599.194Abrir presentación 0001828822-26-000008 Presentado el 5 nov 2026 Disputar esta fila
Gestores del trimestre anterior sin presentación leída para el último

Quizá simplemente no hayan presentado aún: estar ausente de las presentaciones leídas del último trimestre no equivale a una posición vendida.

  • Bain Capital Life Sciences Investors, LLC 8.448.158 SH
  • WELLINGTON MANAGEMENT GROUP LLP 7.864.226 SH
  • BAMCO INC /NY/ 3.225.133 SH
  • Jupiter Topco LLC 2.419.336 SH
  • ALLIANCEBERNSTEIN L.P. 1.924.268 SH
  • Point72 Asset Management, L.P. 1.721.279 SH
  • SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 1.694.651 SH
  • UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1.465.650 SH
  • MILLENNIUM MANAGEMENT LLC 922.893 SH
  • 12 West Capital Management LP 902.500 SH
  • CITADEL ADVISORS LLC 799.883 SH
  • GOLDMAN SACHS GROUP INC 607.387 SH
  • Catalio Capital Management, LP 583.055 SH
  • Rock Springs Capital Management LP 573.500 SH
  • BANK OF AMERICA CORP /DE/ 567.030 SH
  • FRED ALGER MANAGEMENT, LLC 539.160 SH
  • NORTHERN TRUST CORP 537.902 SH
  • Alyeska Investment Group, L.P. 350.000 SH
  • AQR CAPITAL MANAGEMENT LLC 303.220 SH
  • Sixth Street Partners Management Company, L.P. 297.254 SH
  • CHARLES SCHWAB INVESTMENT MANAGEMENT INC 297.254 SH
  • RTW INVESTMENTS, LP 295.000 SH
  • PRICE T ROWE ASSOCIATES INC /MD/ 238.268 SH
  • EMERALD ADVISERS, LLC 154.196 SH
  • ROYAL BANK OF CANADA 145.773 SH
  • Brevan Howard Capital Management LP 136.584 SH
  • WELLS FARGO COMPANY/MN 118.330 SH
  • INTREPID FAMILY OFFICE LLC 110.000 SH
  • NEUBERGER BERMAN GROUP LLC 106.115 SH
  • AMERIPRISE FINANCIAL INC 104.017 SH
  • EMERALD MUTUAL FUND ADVISERS TRUST 94.099 SH
  • GILDER GAGNON HOWE CO LLC 88.615 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 82.295 SH
  • NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 77.366 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 76.400 SH
  • Burkehill Global Management, LP 65.000 SH
  • MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 54.797 SH
  • PRUDENTIAL FINANCIAL INC 54.760 SH
  • Allianz Asset Management GmbH 53.061 SH
  • Corient Private Wealth LP 52.724 SH
  • XTX Topco Ltd 50.826 SH
  • Ghisallo Capital Management LLC 50.000 SH
  • MetLife Investment Management, LLC 47.011 SH
  • Balyasny Asset Management L.P. 46.722 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 36.500 SH
  • CITADEL ADVISORS LLC 36.000 SH
  • LAZARD ASSET MANAGEMENT LLC 34.362 SH
  • Legal General Group Plc 34.020 SH
  • ALLSTATE CORP 29.078 SH
  • Aquatic Capital Management LLC 28.584 SH
  • El Formulario 13F cubre solo posiciones largas en valores de la Sección 13(f): ni posiciones cortas ni valores fuera de esa lista.
  • Un gestor que aún no ha presentado el último trimestre está ausente, no en cero; las presentaciones vencen hasta 45 días después del cierre del trimestre.
  • Una diferencia es la que hay entre dos instantáneas de cierre de trimestre, no una operación.
  • Una posición informada bajo otro gestor puede aparecer también en la presentación de ese gestor; las filas no se suman.
  • No se muestran las posiciones que la lista de valores no puede atribuir a esta empresa o atribuye de forma ambigua.

Titulares del 5 % (Anexos 13D y 13G)

Aquí se leen los anexos presentados en el formato estructurado de la SEC (desde finales de 2024). Los anteriores son texto libre y no se leen.

Titulares del 5 %, el evento más reciente primero, según lo presentado
TitularPorcentaje de la claseAcciones en poderFecha del eventoFormularioFuente
Wellington Management Group LLP Common Stock10.79.232.829,0007/31/2026 Presentado el 6 ago 2026SCHEDULE 13G/AEnmienda 4Abrir presentación 0000902219-26-000218 Disputar esta fila
Wellington Group Holdings LLP Common Stock10.79.232.829,0007/31/2026 Presentado el 6 ago 2026SCHEDULE 13G/AEnmienda 4Abrir presentación 0000902219-26-000218 Disputar esta fila
Wellington Investment Advisors Holdings LLP Common Stock10.79.232.829,0007/31/2026 Presentado el 6 ago 2026SCHEDULE 13G/AEnmienda 4Abrir presentación 0000902219-26-000218 Disputar esta fila
Wellington Management Company LLP Common Stock10.49.232.829,0007/31/2026 Presentado el 6 ago 2026SCHEDULE 13G/AEnmienda 4Abrir presentación 0000902219-26-000218 Disputar esta fila
BCLS Fund III Investments, LP Common Stock, $0.001 par value per share9.808.448.15806/30/2026 Presentado el 14 ago 2026SCHEDULE 13G/AEnmienda 2Abrir presentación 0001193125-26-350334 Disputar esta fila
Wellington Management Group LLP Common Stock9.17.864.226,0006/30/2026 Presentado el 13 ago 2026SCHEDULE 13G/AEnmienda 3Abrir presentación 0000902219-26-000233 Disputar esta fila
Wellington Group Holdings LLP Common Stock9.17.864.226,0006/30/2026 Presentado el 13 ago 2026SCHEDULE 13G/AEnmienda 3Abrir presentación 0000902219-26-000233 Disputar esta fila
Wellington Investment Advisors Holdings LLP Common Stock9.17.864.226,0006/30/2026 Presentado el 13 ago 2026SCHEDULE 13G/AEnmienda 3Abrir presentación 0000902219-26-000233 Disputar esta fila
Wellington Management Company LLP Common Stock8.97.864.226,0006/30/2026 Presentado el 13 ago 2026SCHEDULE 13G/AEnmienda 3Abrir presentación 0000902219-26-000233 Disputar esta fila
BlackRock, Inc. Common Stock5.74.934.92806/30/2026 Presentado el 28 jul 2026SCHEDULE 13GAbrir presentación 0002012383-26-002517 Disputar esta fila
BCLS Fund III Investments, LP Common Stock, $0.001 par value per share12.1810.448.15803/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-226935 Disputar esta fila
HealthCor Partners Management LP COMMON STOCK2.42.082.014,0003/24/2026 Presentado el 31 mar 2026SCHEDULE 13GAbrir presentación 0001519462-26-000003 Disputar esta fila
HealthCor Partners Fund LP COMMON STOCK1.51.248.939,0003/24/2026 Presentado el 31 mar 2026SCHEDULE 13GAbrir presentación 0001519462-26-000003 Disputar esta fila
HealthCor Partners Fund II, L.P. COMMON STOCK1.0833.075,0003/24/2026 Presentado el 31 mar 2026SCHEDULE 13GAbrir presentación 0001519462-26-000003 Disputar esta fila
Wellington Management Group LLP Common Stock14.011.921.247,0002/27/2026 Presentado el 5 mar 2026SCHEDULE 13G/AEnmienda 2Abrir presentación 0000902219-26-000105 Disputar esta fila
Wellington Group Holdings LLP Common Stock14.011.921.247,0002/27/2026 Presentado el 5 mar 2026SCHEDULE 13G/AEnmienda 2Abrir presentación 0000902219-26-000105 Disputar esta fila
Wellington Investment Advisors Holdings LLP Common Stock14.011.921.247,0002/27/2026 Presentado el 5 mar 2026SCHEDULE 13G/AEnmienda 2Abrir presentación 0000902219-26-000105 Disputar esta fila
Wellington Management Company LLP Common Stock13.811.921.247,0002/27/2026 Presentado el 5 mar 2026SCHEDULE 13G/AEnmienda 2Abrir presentación 0000902219-26-000105 Disputar esta fila
Hayfin Management Holdings Limited Class A Common Stock, $0.001 par value0.7633.505,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Heartflow UK Limited Class A Common Stock, $0.001 par value0.6530.61002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Tourmaline LuxCo S.a.r.l. Class A Common Stock, $0.001 par value0.1102.895,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Healthcare Opportunities Fund GP S.a.r.l. Class A Common Stock, $0.001 par value0.7633.505,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Healthcare Opportunities Invest LP Class A Common Stock, $0.001 par value0.7633.505,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin SOF III GP S.a.r.l. Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Special Opportunities Fund III SCSp Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Hostplus GP Limited Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Hostplus LP Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Chief GP Limited Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Chief LP Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
SunHay GP Limited Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
SunHay LP Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Big Cypress GP Limited Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Big Cypress LP Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Hamilton GP Limited Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Hamilton LP Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Opal 2020 GP Limited Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Opal 2020 (A) LP Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Opal 2020 (B) LP Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin SOF II GP Limited Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Special Opportunities Fund II LP Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin SOF III AIV GP S.a.r.l. Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin AUS AIV LP - Hostplus Series Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin Special Opportunities Fund III AIV LP Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Hayfin AUS AIV LP - AUS SOF III Series Class A Common Stock, $0.001 par value0.000,0002/06/2026 Presentado el 11 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001193125-26-216536 Disputar esta fila
Wellington Management Group LLP Common Stock6.95.894.070,0012/31/2025 Presentado el 10 feb 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000902219-26-000068 Disputar esta fila
Wellington Group Holdings LLP Common Stock6.95.894.070,0012/31/2025 Presentado el 10 feb 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000902219-26-000068 Disputar esta fila
Wellington Investment Advisors Holdings LLP Common Stock6.95.894.070,0012/31/2025 Presentado el 10 feb 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000902219-26-000068 Disputar esta fila
Wellington Management Company LLP Common Stock6.95.894.070,0012/31/2025 Presentado el 10 feb 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000902219-26-000068 Disputar esta fila
Hayfin Management Holdings Limited Class A Common Stock, $0.001 par value6.25.283.26409/30/2025 Presentado el 14 nov 2025SCHEDULE 13GAbrir presentación 0001193125-25-282850 Disputar esta fila
Hayfin Heartflow UK Limited Class A Common Stock, $0.001 par value4.33.635.59709/30/2025 Presentado el 14 nov 2025SCHEDULE 13GAbrir presentación 0001193125-25-282850 Disputar esta fila

El porcentaje es de la clase que indica la presentación, según lo declaró el titular. Los miembros de un grupo informan cada uno las acciones del grupo, por lo que las filas no se suman.

Qué se leyó

2.024.280 presentaciones leídas, del 14 jun 2004 al 13 nov 2026: Formularios 3, 3/A, 4, 4/A, 5, 5/A.

Algunos años pueden estar incompletos mientras se sigue leyendo el archivo. Un año con pocas presentaciones aquí no afirma que se hicieran pocas.

Presentaciones leídas, por año de presentación
Año de presentaciónPresentaciones leídas
20151
2016204.322
2017202.494
2018202.048
2019193.638
2020144.184
2021224.474
202240.015
2023199.811
2024117.969
2025235.520
2026254.026

Las presentaciones anteriores a que la SEC exigiera XML se listan, pero no se extraen.

Volver a Heartflow, Inc.